Selected research
Market Structure
Global Non-ionic Iodine Contrast Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Non-ionic Iodine Contrast Media market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Non-ionic Iodine Contrast Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Non-ionic Iodine Contrast Media include YRPG, Hengrui Medicine, BeiLu Pharma, Bayer, Sanochemia, Imax, Guerbet Group, GE Healthcare and Bracco Imaging, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Non-ionic Iodine Contrast Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Non-ionic Iodine Contrast Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Non-ionic Iodine Contrast Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-ionic Iodine Contrast Media market size, projected growth trends, production technologies, key applications, and end-use industries.
Non-ionic Iodine Contrast Media Segment by Company
YRPG
Hengrui Medicine
BeiLu Pharma
Bayer
Sanochemia
Imax
Guerbet Group
GE Healthcare
Bracco Imaging
Non-ionic Iodine Contrast Media Segment by Type
Iopamidol
Iodixanol
Iohexol
Ioversol
Others
Non-ionic Iodine Contrast Media Segment by Application
Hospitals
Clinics
Non-ionic Iodine Contrast Media Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-ionic Iodine Contrast Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-ionic Iodine Contrast Media and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-ionic Iodine Contrast Media.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Non-ionic Iodine Contrast Media market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-ionic Iodine Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-ionic Iodine Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Non-ionic Iodine Contrast Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Iopamidol
- Iodixanol
- Iohexol
- Ioversol
- Others
Applications
- Hospitals
- Clinics
Companies covered
- YRPG
- Hengrui Medicine
- BeiLu Pharma
- Bayer
- Sanochemia
- Imax
- Guerbet Group
- GE Healthcare
- Bracco Imaging
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Non-ionic Iodine Contrast Media Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Non-ionic Iodine Contrast Media Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Non-ionic Iodine Contrast Media Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Non-ionic Iodine Contrast Media Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Non-ionic Iodine Contrast Media Market Dynamics
- 2.1 Non-ionic Iodine Contrast Media Industry Trends
- 2.2 Non-ionic Iodine Contrast Media Industry Drivers
- 2.3 Non-ionic Iodine Contrast Media Industry Opportunities and Challenges
- 2.4 Non-ionic Iodine Contrast Media Industry Restraints
3 Non-ionic Iodine Contrast Media Market by Manufacturers
- 3.1 Global Non-ionic Iodine Contrast Media Revenue by Manufacturers (2021-2026)
- 3.2 Global Non-ionic Iodine Contrast Media Sales by Manufacturers (2021-2026)
- 3.3 Global Non-ionic Iodine Contrast Media Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Non-ionic Iodine Contrast Media Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Non-ionic Iodine Contrast Media Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Non-ionic Iodine Contrast Media Manufacturers, Product Type & Application
- 3.7 Global Non-ionic Iodine Contrast Media Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Non-ionic Iodine Contrast Media Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Non-ionic Iodine Contrast Media Players Market Share by Revenue in 2025
- 3.8.3 2025 Non-ionic Iodine Contrast Media Tier 1, Tier 2, and Tier 3
4 Non-ionic Iodine Contrast Media Market by Type
- 4.1 Non-ionic Iodine Contrast Media Type Introduction
- 4.1.1 Iopamidol
- 4.1.2 Iodixanol
- 4.1.3 Iohexol
- 4.1.4 Ioversol
- 4.1.5 Others
- 4.2 Global Non-ionic Iodine Contrast Media Sales by Type
- 4.2.1 Global Non-ionic Iodine Contrast Media Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Non-ionic Iodine Contrast Media Sales by Type (2021-2032)
- 4.2.3 Global Non-ionic Iodine Contrast Media Sales Market Share by Type (2021-2032)
- 4.3 Global Non-ionic Iodine Contrast Media Revenue by Type
- 4.3.1 Global Non-ionic Iodine Contrast Media Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Non-ionic Iodine Contrast Media Revenue by Type (2021-2032)
- 4.3.3 Global Non-ionic Iodine Contrast Media Revenue Market Share by Type (2021-2032)
5 Non-ionic Iodine Contrast Media Market by Application
- 5.1 Non-ionic Iodine Contrast Media Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Non-ionic Iodine Contrast Media Sales by Application
- 5.2.1 Global Non-ionic Iodine Contrast Media Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Non-ionic Iodine Contrast Media Sales by Application (2021-2032)
- 5.2.3 Global Non-ionic Iodine Contrast Media Sales Market Share by Application (2021-2032)
- 5.3 Global Non-ionic Iodine Contrast Media Revenue by Application
- 5.3.1 Global Non-ionic Iodine Contrast Media Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Non-ionic Iodine Contrast Media Revenue by Application (2021-2032)
- 5.3.3 Global Non-ionic Iodine Contrast Media Revenue Market Share by Application (2021-2032)
6 Global Non-ionic Iodine Contrast Media Sales by Region
- 6.1 Global Non-ionic Iodine Contrast Media Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Non-ionic Iodine Contrast Media Sales by Region (2021-2032)
- 6.2.1 Global Non-ionic Iodine Contrast Media Sales by Region (2021-2026)
- 6.2.2 Global Non-ionic Iodine Contrast Media Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Non-ionic Iodine Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Non-ionic Iodine Contrast Media Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Non-ionic Iodine Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Non-ionic Iodine Contrast Media Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Non-ionic Iodine Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Non-ionic Iodine Contrast Media Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Non-ionic Iodine Contrast Media Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Non-ionic Iodine Contrast Media Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Non-ionic Iodine Contrast Media Revenue by Region
- 7.1 Global Non-ionic Iodine Contrast Media Revenue by Region
- 7.1.1 Global Non-ionic Iodine Contrast Media Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Non-ionic Iodine Contrast Media Revenue by Region (2021-2026)
- 7.1.3 Global Non-ionic Iodine Contrast Media Revenue by Region (2027-2032)
- 7.1.4 Global Non-ionic Iodine Contrast Media Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Non-ionic Iodine Contrast Media Revenue (2021-2032)
- 7.2.2 North America Non-ionic Iodine Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Non-ionic Iodine Contrast Media Revenue (2021-2032)
- 7.3.2 Europe Non-ionic Iodine Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Non-ionic Iodine Contrast Media Revenue (2021-2032)
- 7.4.2 Asia-Pacific Non-ionic Iodine Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Non-ionic Iodine Contrast Media Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Non-ionic Iodine Contrast Media Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 YRPG
- 8.1.1 YRPG Company Information
- 8.1.2 YRPG Business Overview
- 8.1.3 YRPG Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 YRPG Non-ionic Iodine Contrast Media Product Portfolio
- 8.1.5 YRPG Recent Developments
- 8.2 Hengrui Medicine
- 8.2.1 Hengrui Medicine Company Information
- 8.2.2 Hengrui Medicine Business Overview
- 8.2.3 Hengrui Medicine Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Hengrui Medicine Non-ionic Iodine Contrast Media Product Portfolio
- 8.2.5 Hengrui Medicine Recent Developments
- 8.3 BeiLu Pharma
- 8.3.1 BeiLu Pharma Company Information
- 8.3.2 BeiLu Pharma Business Overview
- 8.3.3 BeiLu Pharma Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 BeiLu Pharma Non-ionic Iodine Contrast Media Product Portfolio
- 8.3.5 BeiLu Pharma Recent Developments
- 8.4 Bayer
- 8.4.1 Bayer Company Information
- 8.4.2 Bayer Business Overview
- 8.4.3 Bayer Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Bayer Non-ionic Iodine Contrast Media Product Portfolio
- 8.4.5 Bayer Recent Developments
- 8.5 Sanochemia
- 8.5.1 Sanochemia Company Information
- 8.5.2 Sanochemia Business Overview
- 8.5.3 Sanochemia Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sanochemia Non-ionic Iodine Contrast Media Product Portfolio
- 8.5.5 Sanochemia Recent Developments
- 8.6 Imax
- 8.6.1 Imax Company Information
- 8.6.2 Imax Business Overview
- 8.6.3 Imax Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Imax Non-ionic Iodine Contrast Media Product Portfolio
- 8.6.5 Imax Recent Developments
- 8.7 Guerbet Group
- 8.7.1 Guerbet Group Company Information
- 8.7.2 Guerbet Group Business Overview
- 8.7.3 Guerbet Group Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Guerbet Group Non-ionic Iodine Contrast Media Product Portfolio
- 8.7.5 Guerbet Group Recent Developments
- 8.8 GE Healthcare
- 8.8.1 GE Healthcare Company Information
- 8.8.2 GE Healthcare Business Overview
- 8.8.3 GE Healthcare Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 GE Healthcare Non-ionic Iodine Contrast Media Product Portfolio
- 8.8.5 GE Healthcare Recent Developments
- 8.9 Bracco Imaging
- 8.9.1 Bracco Imaging Company Information
- 8.9.2 Bracco Imaging Business Overview
- 8.9.3 Bracco Imaging Non-ionic Iodine Contrast Media Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Bracco Imaging Non-ionic Iodine Contrast Media Product Portfolio
- 8.9.5 Bracco Imaging Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Non-ionic Iodine Contrast Media Value Chain Analysis
- 9.1.1 Non-ionic Iodine Contrast Media Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Non-ionic Iodine Contrast Media Production Mode & Process
- 9.2 Non-ionic Iodine Contrast Media Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Non-ionic Iodine Contrast Media Distributors
- 9.2.3 Non-ionic Iodine Contrast Media Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst